Showing 221 - 240 results of 105,327 for search '(( e fold decrease ) OR ((( 10 we decrease ) OR ( 5 ((nn decrease) OR (a decrease)) ))))', query time: 1.03s Refine Results
  1. 221
  2. 222

    Visual abstract for "The impact of concession patterns on negotiations: When and why decreasing concessions lead to a distributive disadvantage" by Michael SCHAERER (8645940)

    Published 2023
    “…Finally, we find that recipients can protect themselves against the deleterious effects of decreasing concession by thinking of a target before they enter the negotiation (Study 5).…”
  3. 223

    Total history dependence decreases for small time bins Δ<i>t</i>. by Lucas Rudelt (4059505)

    Published 2021
    “…The smaller the time bin, the higher the risk that noise in the spike emission reduces the overall predictability or history dependence in the spiking, whereas an overly large time bin holds the risk of destroying coding relevant time information in the spike train. Thus, we chose the smallest time bin Δ<i>t</i> = 5 ms that does not yet show a substantial decrease in <i>R</i><sub>tot</sub>. …”
  4. 224

    The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness. by Gui Araujo (22170819)

    Published 2025
    “…The connectance of invading species was drawn from a uniform distribution between 0.05 and 0.5. In speciation, offspring species had up to 5 interactions differing from the parent species, chosen randomly (, see Methods). …”
  5. 225
  6. 226
  7. 227
  8. 228
  9. 229

    The I827K substitution destabilizes the 3D fold of E6AP<sup>C-lobe</sup> (residues 761–875). by Steven A. Beasley (9099461)

    Published 2020
    “…<p>(A) The assigned <sup>1</sup>H-<sup>15</sup>N-HSQC spectrum of 3.5 mM human E6AP catalytic C-lobe (residues 761–875) using the one-letter amino acid code and residue number according to the human E6AP sequence. …”
  10. 230
  11. 231
  12. 232
  13. 233
  14. 234
  15. 235
  16. 236
  17. 237
  18. 238

    Table_1_Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.docx by Ha Young Jang (1522204)

    Published 2022
    “…The cancer risk showed a tendency to decrease rapidly when LTRAs were used in high dose (aHR = 0.56, 95% CI = 0.40–0.79) or for longer durations of more than 3 years (aHR = 0.68, 95% CI = 0.60–0.76) and 5 years (aHR = 0.33, 95% CI = 0.26–0.42). …”
  19. 239
  20. 240